Investigar el cáncer con los pacientes: de destinatarios a parte activa de la investigació... 23/09/2026 Salud Acceso a la innovación Medicamentos innovadores Vanesa Abón Escalona, responsable del Programa Patient Advocacy AECC, explica cómo incorporar la experiencia de las... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
mRNA vaccines for the future of medicine 15/09/2026 Healthcare Coronavirus Innovative drugs The COVID-19 pandemic transformed mRNA technology into a large-scale clinical platform and demonstrated its ability to... Partners - GENESIS Biomed
ORYZON to participate in upcoming events in September and October 11/09/2026 Healthcare Innovative drugs International Oryzon Genomics will participate in several international investment and capital markets events in the United States and... Partners - Oryzon Genomics
CONNECTA Therapeutics Announces Financing to Advance Clinical Development of Fragile X Sy... 10/09/2026 Healthcare Rare diseases Innovative drugs €3.1 million financing led by new investor Clave Capital, with participation from existing investors. Partners - CONNECTA THERAPEUTICS
#BIOSPAIN2026 | Abstract – Accelerating Cell & Gene Therapy Impact through analytical exce... 08/09/2026 Healthcare Innovative drugs Advanced therapies Cell and gene therapies are transforming biomedical innovation, but their development presents significant challenges in... Partners
BCN HEALTH publishes a systematic review highlighting the cost effectiveness of novel neph... 08/09/2026 Healthcare Access to innovation Innovative drugs BCN HEALTH has published the study “Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2... Partners - BCN Health
BCN HEALTH presents new analyses on hepatitis delta vs. hepatitis B healthcare costs in Sp... 03/09/2026 Healthcare Access to innovation Innovative drugs BCN HEALTH participated in the European Association for the Study of the Liver (EASL) International Liver Congress (ILC... Partners - BCN Health
Atlas Molecular Pharma to Begin Dosing First Patients in Phase 2 Trial of ATL-001 for Cong... 03/09/2026 Healthcare Rare diseases Innovative drugs Atlas Molecular Pharma, a Basque biotech developing pharmacological chaperone therapies for rare diseases, announces... Partners - Atlas Molecular Pharma
Batea Oncology and dsm-firmenich Partner to Support Clinical Development of GlioHook® for ... 02/09/2026 Healthcare Innovative drugs Advanced therapies Batea Oncology and dsm-firmenich are building on a longstanding collaboration dedicated to advancing GlioHook®, an... Partners - BATEA ONCOLOGY S.L.
ORYZON announces Notice of Allowance for U.S. patent application covering iadademstat com... 31/08/2026 Healthcare Drug discovery Innovative drugs Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination with gilteritinib in... Partners - Oryzon Genomics
